Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:March 24, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:March 24, 2023Withdrawn
Condition(s):Breast Cancer MetastaticLast Updated:July 7, 2023Completed
Condition(s):Metastatic Breast CancerLast Updated:February 23, 2022Unknown status
Condition(s):Breast CancerLast Updated:November 4, 2022Recruiting
Condition(s):Breast Neoplasms; Neoplasm MetastasisLast Updated:February 28, 2024Recruiting
Condition(s):Breast CancerLast Updated:October 25, 2021Withdrawn
Condition(s):Breast Cancer; Advanced Breast CancerLast Updated:February 8, 2024Recruiting
Condition(s):Breast Cancer Brain MetastasesLast Updated:March 22, 2024Recruiting
Condition(s):Advanced Breast CancerLast Updated:January 22, 2019Unknown status
Condition(s):Locally Advanced or Metastatic Breast CancerLast Updated:March 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.